Are you eagerly waiting to find out if you’ve been allotted shares in the Exicom TeleSystems IPO? Look no further! In this guide, we’ll walk you through the steps to check your allotment status and ensure you stay informed.
About Exicom Tele-Systems:
Exicom Tele Systems Limited specializes in power management solutions across two primary business segments: the critical power business and the EV charger business. Under the Critical Power Business, the company is engaged in the design, manufacturing, and servicing of DC power systems and Li-ion energy storage solutions tailored for telecommunication sites. Concurrently, in the EV Charger Business segment, Exicom offers smart charging systems designed for residential, commercial, and public usage within India
How to Check Allotment Status
- Visit the Registrar’s Website:
- Go to the Link Intime website, which is the registrar for Exicom TeleSystems IPO.
- Look for the IPO allotment section.
- Select Exicom Tele-Systems:
- Choose “Exicom Tele-Systems” from the drop-down menu of issuer companies.
- Enter Details:
- You can check your allotment status using any of the following details:
- PAN Number: Enter your PAN number.
- Application Number: Use the application number provided during IPO application.
- DP Client ID/Demat Account Number: If you have a Demat account, enter the DP client ID.
- You can check your allotment status using any of the following details:
- Click on ‘Submit’:
- Tap the ‘Submit’ button.
- The screen will display the shares applied by you and the shares allotted to you.
Exicom Tele-Systems IPO Important Information
- Allotment Date: The allotment for Exicom TeleSystems IPO is expected to be finalized on Friday, March 1, 2024.
- Listing Date: The IPO will list on both BSE and NSE on Tuesday, March 5, 2024.
- Price Band: The price band for Exicom TeleSystems IPO is set at ₹135 to ₹142 per share.
- Minimum Lot Size: The minimum lot size for an application is 100 shares.
Tele-Systems IPO Subscription Status
The Subscription Status for the GPT Healthcare IPO reveals staggering demand across all investor categories, with Qualified Institutional Buyers oversubscribing by 121.80 times, Non-Institutional Investors by 153.00 times, Retail Individual Investors by 117.66 times, resulting in an overall oversubscription of 129.16 times.
